
Medivis is a pioneering company in augmented reality (AR) and artificial intelligence (AI) for surgical navigation. Founded in 2016 and based in New York City, Medivis offers FDA-cleared products like SurgicalAR and Spine Navigation, which enhance surgical precision and improve patient outcomes. Their innovative technology integrates AR with real-time data, empowering surgeons with intuitive tools for better decision-making. With over 2000 surgeries performed and 40 hospitals using their solutions, Medivis is positioned as a leader in the med-tech industry, driving advancements in surgical procedures and clinical training.

Medivis is a pioneering company in augmented reality (AR) and artificial intelligence (AI) for surgical navigation. Founded in 2016 and based in New York City, Medivis offers FDA-cleared products like SurgicalAR and Spine Navigation, which enhance surgical precision and improve patient outcomes. Their innovative technology integrates AR with real-time data, empowering surgeons with intuitive tools for better decision-making. With over 2000 surgeries performed and 40 hospitals using their solutions, Medivis is positioned as a leader in the med-tech industry, driving advancements in surgical procedures and clinical training.
Founded: 2016
Headquarters: New York City
Product focus: AR- and AI-powered surgical visualization and navigation (SurgicalAR; Spine and Cranial Navigation)
Regulatory: FDA 510(k) clearances for Spine and Cranial Navigation
Recent raise: $20M Series A (Jun 13, 2023) led by Thrive Capital
Surgical visualization and navigation for improved precision and patient outcomes.
2016
Medical technology / Healthtech
$20,000,000
Participants included Initialized Capital and Mayo Clinic; additional notable participants reported.
$2,300,000
“Series A led by Thrive Capital with participation from institutional and notable individual investors (Initialized Capital, Mayo Clinic, Bob Iger, Kevin Durant)”